Oxygenta Pharmaceutical Limited (BOM:524636)

Market Cap	2.20B
Revenue (ttm)	1.12B
Net Income (ttm)	-165.04M
Shares Out	36.98M
EPS (ttm)	-4.47
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,363
Average Volume	2,831
Open	57.00
Previous Close	57.00
Day's Range	57.00 - 58.50
52-Week Range	51.31 - 133.50
Beta	0.51
RSI	57.67
Earnings Date	Feb 14, 2026

About Oxygenta Pharmaceutical

Oxygenta Pharmaceutical Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India. It offers active pharmaceuticals ingredients and commercial intermediates. The company was formerly known as S.S. Organics Limited and changed its name to Oxygenta Pharmaceutical Limited in February 2022. Oxygenta Pharmaceutical Limited was incorporated in 1990 and is based in Hyderabad, India.

• Industry: Pharmaceutical Preparations
• Founded: 1990
• Employees: 175
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524636

Financial Performance

In 2024, Oxygenta Pharmaceutical's revenue was 1.09 billion, an increase of 175.71% compared to the previous year's 396.42 million. Losses were -96.83 million, 178.3% more than in 2023.